Identification of spectrum of persistent post-COVID-19 symptoms and their duration in Central India: A pilot study

OBJECTIVES: To uncover numerous post-COVID symptoms in individuals after SARS-CoV-2 infection and to raise concerns about the consequences for health care planning. METHODOLOGY: Patients declared negative with RTPCR and discharged from the hospital were followed up for three months. RESULTS: The maj...

Descripción completa

Detalles Bibliográficos
Autores principales: Sudha, T.Y. Sree, Sasanka, K. S. B. S. Krishna, Thangaraju, Pugazhenthan, Kuotsu, Ruuzeno, William, Akanksha G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10040991/
https://www.ncbi.nlm.nih.gov/pubmed/36994011
http://dx.doi.org/10.4103/jfmpc.jfmpc_801_22
Descripción
Sumario:OBJECTIVES: To uncover numerous post-COVID symptoms in individuals after SARS-CoV-2 infection and to raise concerns about the consequences for health care planning. METHODOLOGY: Patients declared negative with RTPCR and discharged from the hospital were followed up for three months. RESULTS: The majority of patients who suffered from weakness since discharge are 63 (25.40%), body aches 40 (16.12%), loss of taste 26 (10.48%), and loss of smell 18 (7.25%). The total of reinfected patients in the 4(th) week was 9 (3.62%), in the 6(th) week 10 (4.03%), in the 8(th) week 7 (2.82%), and in the 12(th) week 11 (4.43%). A total of 54.7% of individuals still have the persistence of symptoms at the end of the 12(th) week. CONCLUSIONS: A significant number of participants developed long-term health issues as a result of post-COVID-19 syndrome. Our findings highlight the importance of initial preventive measures and patient-centered benefit programs in reducing post-COVID-19 complications.

Ejemplares similares